ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma
Affiliations: Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305‑8577, Japan, International Medical Center, University of Tsukuba Affiliated Hospital, Tsukuba, Ibaraki 305‑8576, Japan, Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Ibaraki 309‑1793, Japan, Life Science Research Center, Technology Research Laboratory, Shimadzu Corporation, Kyoto 604‑8511, Japan, Department of Endocrinology and Metabolism, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305‑8575, Japan
- Published online on: November 26, 2021 https://doi.org/10.3892/or.2021.8234
- Article Number: 23
Copyright: © Tanaka et al. This is an open access article distributed under the terms of Creative Commons Attribution License.